Monitoring cardiac output is essential in the treatment of critically ill patients. It may improve the indication and choice of treatment in a hemodynamically unstable patient. Furthermore, the ...
Levosimendan is an inotropic agent that has been shown in small studies to prevent or treat the low cardiac output syndrome after cardiac surgery. In a multicenter, randomized, placebo-controlled, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback